Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries: A Breast Health Global Initiative 2013 consensus statement

Breast

Volumn 22, Issue 5, 2013, Pages 593-605

  Cardoso, Fatima ^a   Bese, Nuran ^b   Distelhorst, Sandra R ^c   Bevilacqua, Jose Luiz B ^d   Ginsburg, Ophira ^e   Grunberg, Steven M ^f   Gralla, Richard J ^g   Steyn, Ann ^h   Pagani, Olivia ⁱ   Partridge, Ann H ^j   Knaul, Felicia Marie ^k,l   Aapro, Matti S ^m   Andersen, Barbara L ⁿ   Thompson, Beti ^c   Gralow, Julie R ^c,o   Anderson, Benjamin O ^c,o  

^a Champalimaud Cancer Center   (Portugal)

^b Acibadem Maslak Hospital   (Turkey)

^c Fred Hutchinson Cancer Research Center   (United States)

^d HOSPITAL SÍRIO LIBANÊS   (Brazil)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

^f Multinational Association of Supportive Care in Cancer   (United States)

^g Albert Einstein University   (United States)

^h Reach to Recovery International Reach to Recovery South Africa   (South Africa)

ⁱ European School of Oncology and Institute of Oncology of Southern Switzerland   (Switzerland)

^j DANA FARBER CANCER INSTITUTE   (United States)

^k HARVARD UNIVERSITY   (United States)

^l Tómatelo a Pecho Mexican Health Foundation FUNSALUD   (Mexico)

^m CLINIQUE DE GENOLIER   (Switzerland)

ⁿ OHIO STATE UNIVERSITY   (United States)

^o UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

Breast cancer; Low and middle income countries; Resource allocations; Supportive care; Treatment toxicities

Indexed keywords

ANTACID AGENT; ANTHRACYCLINE DERIVATIVE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CORTICOSTEROID; CYTOTOXIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; LACTULOSE; LAXATIVE; LOPERAMIDE; LORAZEPAM; MORPHINE; NARCOTIC ANALGESIC AGENT; NEUROKININ 1 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROKINETIC AGENT; SEROTONIN ANTAGONIST; TAXANE DERIVATIVE;

ADVERSE DRUG REACTION; ALOPECIA; ARTHRALGIA; ATTENTION DISTURBANCE; BLOOD TOXICITY; BONE PAIN; BREAST CANCER; CANCER FATIGUE; CARDIOTOXICITY; CAREGIVER SUPPORT; CELLULITIS; CHEMOTHERAPY INDUCED EMESIS; COGNITION; CONCENTRATION LOSS; CONGESTIVE HEART FAILURE; CONSTIPATION; CULTURAL SENSITIVITY; DEVELOPING COUNTRY; DIARRHEA; EXTRAVASATION; GASTROINTESTINAL TOXICITY; HAND FOOT SYNDROME; HEALTH CARE DELIVERY; HUMAN; INFECTION; INSOMNIA; LYMPHEDEMA; MEDICAL EDUCATION; MUCOSA INFLAMMATION; MUSCULOSKELETAL DISEASE; NAIL DISEASE; NAIL INFECTION; NEUROPATHIC PAIN; NEUROTOXICITY; OVARY INSUFFICIENCY; PAIN; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; SEXUAL DYSFUNCTION; SHORT TERM MEMORY; SIDE EFFECT; SKIN DISEASE; SPIRITUAL CARE; SUPPORTIVE CARE; THROMBOCYTOPENIA; WOMEN'S HEALTH;

BREAST CANCER; LOW- AND MIDDLE-INCOME COUNTRIES; RESOURCE ALLOCATIONS; SUPPORTIVE CARE; TREATMENT TOXICITIES;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DEPRESSION; DEVELOPING COUNTRIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FATIGUE; FEMALE; HEALTH PERSONNEL; HUMANS; PAIN MANAGEMENT; PATIENT EDUCATION AS TOPIC; POSTOPERATIVE COMPLICATIONS; RESOURCE ALLOCATION;

EID: 84884149244     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.07.050     Document Type: Review

References (198)

1. Ganz P.A. Monitoring the physical health of cancer survivors: a survivorship-focused medical history. JClin Oncol 2006, 24(32):5105-5111.
2. Stanton A.L. Psychosocial concerns and interventions for cancer survivors. JClin Oncol 2006, 24(32):5132-5137.
3. Knaul F., Gralow J., Atun R., Bhadelia A. Closing the cancer divide 2012, Global Equity Initiative, Harvard University, Cambridge, MA.
4. Schmid-Buchi S., van den Borne B., Dassen T., Halfens R.J. Factors associated with psychosocial needs of close relatives of women under treatment for breast cancer. JClin Nurs 2011, 20(7-8):1115-1124.
5. Liao M.N., Chen S.C., Lin Y.C., Hsu Y.H., Hung H.C., Wang C.H., et al. Changes and predictors of unmet supportive care needs in Taiwanese women with newly diagnosed breast cancer. Oncol Nurs Forum 2012, 39(5):E380-E389.
6. Li W.W., Lam W.W., Au A.H., Ye M., Law W.L., Poon J., et al. Interpreting differences in patterns of supportive care needs between patients with breast cancer and patients with colorectal cancer. Psychooncology 2012, 22(4):792-798.
7. Saatei E., Akin S., Akpinaar E. Do the unmet needs affect the quality of life in breast cancer patients?. West Indian Med J 2007, 56:253-257.
8. Ganz P., Yip C., Gralow J., Distelhorst S.R., Albain K.S., Andersen B.L., et al. Supportive care after curative treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013, 22:606-615.
9. Cleary J., Ddungu H., Distelhorst S.R., Riponanti C., Rodin G., Bushnaq M.A., et al. Supportive and palliative care for metastatic breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013, 22:616-627.
10. Anderson B.O., Cazap E., El Saghir N.S., Yip C.H., Khaled H.M., Otero I.V., et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011, 12(4):387-398.
11. Anderson B.O., Yip C.H., Smith R.A., Shyyan R., Sener S.F., Eniu A., et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 2008, 113(Suppl.8):2221-2243.
12. Barni S., Venturini M., Molino A., Donadio M., Rizzoli S., Maiello E., et al. Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM). Tumori 2011, 97(5):559-563.
13. Payne S., Chan N., Davies A., Poon E., Connor S., Goh C. Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 2012, 13(11):e492-e500.
14. Grunfeld E., Dhesy-Thind S., Levine M. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005, 172(10):1319-1320.
15. Khatcheressian J.L., Wolff A.C., Smith T.J., Grunfeld E., Muss H.B., Vogel V.G., et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. JClin Oncol 2006, 24(31):5091-5097.
16. Khatcheressian J.L., Hurley P., Bantug E., Esserman L.J., Grunfeld E., Halberg F., et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. JClin Oncol 2013, 31(7):961-965.
17. Aebi S., Davidson T., Gruber G., Cardoso F. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011, 22(Suppl.6):vi12-vi24.
18. Cardoso F., Harbeck N., Fallowfield L., Kyriakides S., Senkus E. Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012, 23(Suppl.7):vii11-vii19.
19. Cardoso F., Costa A., Norton L., Cameron D., Cufer T., Fallowfield L., et al. 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast 2012, 21(3):242-252.
20. NCCN.National Comprehensive Cancer Network Breast cancer. Version 3 2013, Version 1. Available at:. http://www.nccn.org.
21. SIGN Management of breast cancer in women: a national clinical guideline 2005, SIGN: Scottish Intercollegiate Guidelines Network, Available at:. http://www.SIGN.AC.uk.
22. Shamieh O., Jazieh A.R. Modification and implementation of NCCN guidelines on palliative care in the Middle East and North Africa region. JNatl Compr Cancer Netw 2010, 8(Suppl.3):S41-S47.
23. Clinical practice guidelines for the management of breast cancer Nov 2010, Ministry of Health Malaysia, Available at:. http://www.acadmed.org.my, 2nd ed.
24. Alvarez Lopez I., de la Haba Rodriguez J., Ruiz Simon A., Bellet Ezquerra M., Calvo Martinez L., Garcia Estevez L., et al. SEOM clinical guidelines for thetreatment of metastatic breast cancer. Clin Transl Oncol 2010, 12(11):719-723.
25. Abulkhair O., Saghir N., Sedky L., Saadedin A., Elzahwary H., Siddiqui N., et al. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. JNatl Compr Cancer Netw 2010, 8(Suppl.3):S8-S15.
26. Munshi A., Gupta S., Anderson B., Yarnold J., Parmar V., Jalali R., et al. Guidelines for locoregional therapy in primary breast cancer in developing countries: the results of an expert panel at the 8(th) Annual Women's Cancer Initiative - Tata Memorial Hospital (WCI-TMH) Conference. Indian J Med Paediatr Oncol 2012, 33(2):112-122.
27. Biganzoli L., Wildiers H., Oakman C., Marotti L., Loibl S., Kunkler I., et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012, 13(4):e148-e160.
28. NCCN.National Comprehensive Cancer Network Senior adult oncology. Version 2 2012, Available at:. http://www.nccn.org.
29. Cardoso F., Loibl S., Pagani O., Graziottin A., Panizza P., Martincich L., et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer 2012, 48(18):3355-3377.
30. De Vos F.Y., van Laarhoven H.W., Laven J.S., Themmen A.P., Beex L.V., Sweep C.G., et al. Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guideline. Crit Rev Oncol Hematol 2012, 84(2):252-260.
31. Ripamonti C.I., Santini D., Maranzano E., Berti M., Roila F. Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 2012, 23(Suppl.7):vii139-vii154.
32. NCCN.National Comprehensive Cancer Network Adult pain. Version 1 2012, Available at:. http://www.nccn.org.
33. WHO. World Health Organization: pain ladder. Available at: http://www.who.int/cancer/palliative/painladder/en/.
34. Howell D., Keller-Olaman S., Oliver T.K., Hack T.F., Broadfield L., Biggs K., et al. Apan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol 2013, 20(3):e233-e246.
35. NCCN.National Comprehensive Cancer Network Cancer related fatigue. Version 1 2012, Available from:. http://www.nccn.org.
36. Schrijvers D., De Samblanx H., Roila F. Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use. Ann Oncol 2010, 21(Suppl.5):v244-v247.
37. Howell D., Oliver T.K., Keller-Olaman S., Davidson J., Garland S., Samuels C., et al. Apan-Canadian practice guideline: prevention, screening, assessment, and treatment of sleep disturbances in adults with cancer. Support Care Cancer 2013, [Epub ahead of print].
38. Harris S.R., Schmitz K.H., Campbell K.L., McNeely M.L. Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals. Cancer 2012, 118(Suppl.8):2312-2324.
39. Roila F., Herrstedt J., Gralla R.J., Tonato M. Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference. Support Care Cancer 2011, 19(Suppl.1):S63-S65.
40. Olver I., Clark-Snow R.A., Ballatori E., Espersen B.T., Bria E., Jordan K. Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential. Support Care Cancer 2011, 19(Suppl.1):S33-S36.
41. Feyer P.C., Maranzano E., Molassiotis A., Roila F., Clark-Snow R.A., Jordan K. Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009. Support Care Cancer 2011, 19(Suppl.1):S5-S14.
42. Roila F., Herrstedt J., Aapro M., Gralla R.J., Einhorn L.H., Ballatori E., et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 2010, 21(Suppl.5):v232-v243.
43. NCCN.National Comprehensive Cancer Network Antiemesis. Version 1 2012, Available from:. http://www.nccn.org.
44. Keefe D.M., Schubert M.M., Elting L.S., Sonis S.T., Epstein J.B., Raber-Durlacher J.E., et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007, 109(5):820-831.
45. Benson A.B., Ajani J.A., Catalano R.B., Engelking C., Kornblau S.M., Martenson J.A., et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. JClin Oncol 2004, 22(14):2918-2926.
46. Rayner L., Price A., Hotopf M., Higginson I.J. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 2011, 47(5):702-712.
47. Howell D., Keller-Olaman S., Oliver T., Hack T., Broadfield L., Biggs K., et al. Apan-Canadian practice guideline: screening, assessment and care of psychosocial distress (depression, anxiety) in adults with cancer 2010, Canadian Partnership Against Cancer (Cancer Journey Action Group) and the Canadian Association of Psychosocial Oncology, Toronto.
48. NCCN.National Comprehensive Cancer Network Distress management. Version 3 2012, Available from:. http://www.nccn.org.
49. Rock C.L., Doyle C., Demark-Wahnefried W., Meyerhardt J., Courneya K.S., Schwartz A.L., et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 2012, 62(4):242-274.
50. Schmitz K.H., Courneya K.S., Matthews C., Demark-Wahnefried W., Galvao D.A., Pinto B.M., et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010, 42(7):1409-1426.
51. Van Poznak C.H., Von Roenn J.H., Temin S. American Society of Clinical Oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer. JOncol Pract 2011, 7(2):117-121.
52. Hillner B.E., Ingle J.N., Berenson J.R., Janjan N.A., Albain K.S., Lipton A., et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. JClin Oncol 2000, 18(6):1378-1391.
53. Hadji P., Aapro M.S., Body J.J., Bundred N.J., Brufsky A., Coleman R.E., et al. Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment. Ann Oncol 2011, 22(12):2546-2555.
54. Aapro M.S., Bohlius J., Cameron D.A., Dal Lago L., Donnelly J.P., Kearney N., et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 2011, 47(1):8-32.
55. Berliner J.L., Fay A.M., Cummings S.A., Burnett B., Tillmanns T. NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. JGenet Couns 2013, 22(2):155-163.
56. NCI Spirituality in cancer care 2012, National Cancer Institute, USA, Available at:. http://www.cancer.gov/cancertopics/pdq/supportivecare/spirituality.
57. Andersen B.L., Kiecolt-Glaser J.K., Glaser R. Abiobehavioral model of cancer stress and disease course. Am Psychol 1994, 49(5):389-404.
58. Andersen B.L., Farrar W.B., Golden-Kreutz D., Kutz L.A., MacCallum R., Courtney M.E., et al. Stress and immune responses after surgical treatment for regional breast cancer. JNatl Cancer Inst 1998, 90(1):30-36.
59. Wu S.M., Andersen B.L. Stress generation over the course of breast cancer survivorship. JBehav Med 2010, 33(3):250-257.
60. Yu E.S., Shim E.J., Kim H.K., Hahm B.J., Park J.H., Kim J.H. Development of guidelines for distress management in Korean cancer patients. Psychooncology 2012, 21(5):541-549.
61. Mattioli V., Montanaro R., Romito F. The Italian response to cancer survivorship research and practice: developing an evidence base for reform. JCancer Surviv 2010, 4(3):284-289.
62. So W.K., Marsh G., Ling W.M., Leung F.Y., Lo J.C., Yeung M., et al. Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs 2010, 14(1):17-22.
63. Alacacioglu A., Yavuzsen T., Dirioz M., Yilmaz U. Quality of life, anxiety and depression in Turkish breast cancer patients and in their husbands. Med Oncol 2009, 26(4):415-419.
64. Jaiyesimi A.O., Sofela E.A., Rufai A.A. Health related quality of life and its determinants in Nigerian breast cancer patients. Afr J Med Med Sci 2007, 36(3):259-265.
65. Kim S.H., Son B.H., Hwang S.Y., Han W., Yang J.H., Lee S., et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. JPain Symptom Manage 2008, 35(6):644-655.
66. Pandey M., Singh S.P., Behere P.B., Roy S.K., Singh S., Shukla V.K. Quality of life in patients with early and advanced carcinoma of the breast. Eur J Surg Oncol 2000, 26(1):20-24.
67. Palesh O.G., Collie K., Batiuchok D., Tilston J., Koopman C., Perlis M.L., et al. Alongitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 2007, 75(1):37-44.
68. Nuhu F.T., Odejide O.A., Adebayo K.O., Yusuf A.J. Psychological and physical effects of pain on cancer patients in Ibadan, Nigeria. Afr J Psychiatry 2009, 12(1):64-70.
69. Kleiboer A., Bennett F., Hodges L., Walker J., Thekkumpurath P., Sharpe M. The problems reported by cancer patients with major depression. Psychooncology 2011, 20(1):62-68.
70. Alcalar N., Ozkan S., Kucucuk S., Aslay I., Ozkan M. Association of coping style, cognitive errors and cancer-related variables with depression in women treated for breast cancer. Jpn J Clin Oncol 2012, 42(10):940-947.
71. Peterman A.H., Fitchett G., Brady M.J., Hernandez L., Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy - spiritual Well-being Scale (FACIT-Sp). Ann Behav Med 2002, 24(1):49-58.
72. Lagman R.A., Yoo G.J., Levine E.G., Donnell K.A., Lim H.R. "Leaving it to god" religion and spirituality among Filipina immigrant breast cancer survivors. JRelig Health 2012, [Epub ahead of print].
73. Tate J.D. The role of spirituality in the breast cancer experiences of African American women. JHolist Nurs 2011, 29(4):249-255.
74. Ahmad F., Muhammad M., Abdullah A.A. Religion and spirituality in coping with advanced breast cancer: perspectives from Malaysian Muslim women. JRelig Health 2011, 50(1):36-45.
75. Gullate M. The influence of spirituality and religiosity on breast cancer screening delay in African American women: application of the theory of reasoned action and planned behavior (TRA/TPB). ABNF J 2006, 17(2):89-94.
76. Harandy T.F., Ghofranipour F., Montazeri A., Anoosheh M., Bazargan M., Mohammadi E., et al. Muslim breast cancer survivor spirituality: coping strategy or health seeking behavior hindrance?. Health Care Women Int 2010, 31(1):88-98.
77. Liu Y., Malin J.L., Diamant A.L., Thind A., Maly R.C. Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role ofprovider-patient communication. Breast Cancer Res Treat 2013, 137(3):829-836.
78. Sherman K.A., Koelmeyer L. Psychosocial predictors of adherence to lymphedema risk minimization guidelines among women with breast cancer. Psychooncology 2012, 22(5):1120-1126.
79. Iskandarsyah A., Klerk C.D., Suardi D.R., Soemitro M.P., Sadarjoen S.S., Passchier J. Psychosocial and cultural reasons for delay in seeking help and nonadherence to treatment in Indonesian women with breast cancer: a qualitative study. Health Psychol 2013, [Epub ahead of print].
80. Ell K., Vourlekis B., Xie B., Nedjat-Haiem F.R., Lee P.J., Muderspach L., et al. Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation. Cancer 2009, 115(19):4606-4615.
81. Chou P.L., Lin C.C. Apain education programme to improve patient satisfaction with cancer pain management: a randomised control trial. JClin Nurs 2011, 20(13-14):1858-1869.
82. Thind A., Liu Y., Maly R.C. Patient satisfaction with breast cancer follow-up care provided by family physicians. JAm Board Fam Med 2011, 24(6):710-716.
83. Anderson R., Barbara A., Feldman S. What patients want: a content analysis of key qualities that influence patient satisfaction. JMed Pract Manage 2007, 22(5):255-261.
84. Liang W., Burnett C.B., Rowland J.H., Meropol N.J., Eggert L., Hwang Y.T., et al. Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. JClin Oncol 2002, 20(4):1008-1016.
85. Yeo W., Kwan W.H., Teo P.M., Nip S., Wong E., Hin L.Y., et al. Psychosocial impact of breast cancer surgeries in Chinese patients and their spouses. Psychooncology 2004, 13(2):132-139.
86. Odigie V.I., Tanaka R., Yusufu L.M., Gomna A., Odigie E.C., Dawotola D.A., et al. Psychosocial effects of mastectomy on married African women in Northwestern Nigeria. Psychooncology 2010, 19(8):893-897.
87. Pauwels E., De Bourdeaudhuij I., Charlier C., Lechner L., Van Hoof E. Psychosocial characteristics associated with breast cancer survivors' intimate partners' needs for information and support after primary breast cancer treatment. JPsychosoc Oncol 2012, 30(1):1-20.
88. Adirim T., Chafranskaia A., Nyhof-Young J. Investigating the impact of socioeconomic status on the effectiveness of a pamphlet on achieving and maintaining bone health in breast cancer survivors: a patient education resource development primer. JCancer Educ 2012, 27(1):54-58.
89. Ryhanen A.M., Siekkinen M., Rankinen S., Korvenranta H., Leino-Kilpi H. The effects of Internet or interactive computer-based patient education in the field of breast cancer: a systematic literature review. Patient Educ Couns 2010, 79(1):5-13.
90. Joseph G., Beattie M.S., Lee R., Braithwaite D., Wilcox C., Metrikin M., et al. Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT). JGenet Couns 2010, 19(5):447-462.
91. Harless W.G., Zier M.A., Harless M.G., Duncan R.C., Braun M.A., Willey S., et al. Evaluation of a virtual dialogue method for breast cancer patient education. Patient Educ Couns 2009, 76(2):189-195.
92. Jibaja-Weiss M.L., Volk R.J., Granch T.S., Nefe N.E., Spann S.J., Aoki N., et al. Entertainment education for informed breast cancer treatment decisions in low-literate women: development and initial evaluation of a patient decision aid. JCancer Educ 2006, 21(3):133-139.
93. Knoerl A.M., Esper K.W., Hasenau S.M. Cultural sensitivity in patient health education. Nurs Clin North Am 2011, 46(3):335-340. vii.
94. Marks R. Ethics and patient education: health literacy and cultural dilemmas. Health Promot Pract 2009, 10(3):328-332.
95. Ho M.J., Yao G., Lee K.L., Beach M.C., Green A.R. Cross-cultural medical education: can patient-centered cultural competency training be effective in non-Western countries?. Med Teach 2008, 30(7):719-721.
96. Reynolds P.P., Kamei R.K., Sundquist J., Khanna N., Palmer E.J., Palmer T. Using the PRACTICE mnemonic to apply cultural competency to genetics in medical education and patient care. Acad Med 2005, 80(12):1107-1113.
97. Tercyak K.P., Mays D., DeMarco T.A., Sharff M.E., Friedman S. Results of an online community needs assessment for psychoeducational interventions among partners of hereditary breast cancer previvors and survivors. JMed Internet Res 2012, 14(1):e15.
98. Doumit M.A., El Saghir N., Abu-Saad Huijer H., Kelley J.H., Nassar N. Living with breast cancer, a Lebanese experience. Eur J Oncol Nurs 2010, 14(1):42-48.
99. Ozalp E., Soygur H., Cankurtaran E., Turhan L., Akbiyik D., Geyik P. Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psychooncology 2008, 17(7):668-675.
100. Turhal N.S., Dane F., Sinav H., Yalcin N., Khorshidi Z., Zeynep-Yalcin Z. Anxiety and depression in Turkish breast cancer patients. JBUON 2010, 15(4):720-725.
101. Jang J.E., Kim S.W., Kim S.Y., Kim J.M., Park M.H., Yoon J.H., et al. Religiosity, depression, and quality of life in Korean patients with breast cancer: a 1-year prospective longitudinal study. Psychooncology 2013, 24(4):922-929.
102. Gil F., Grassi L., Travado L., Tomamichel M., Gonzalez J.R. Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer 2005, 13(8):600-606.
103. Aukst-Margetic B., Margetic B. Usage of diagnostic questionnaire for depressive patients versus center for epidemiologic studies of depression scale in breast cancer patients. Psychiatr Danub 2004, 16(4):315-321.
104. Khan M.A., Bahadur A.K., Agarwal P.N., Sehgal A., Das B.C. Psychosocial disorders in women undergoing postoperative radiation and chemotherapy for breast cancer in India. Indian J Cancer 2010, 47(3):296-303.
105. Slovacek L., Slovackova B., Slanska I., Petera J., Priester P. Quality of life and depression among metastatic breast cancer patients. Med Oncol 2010, 27(3):958-959.
106. Alacacioglu A., Binicier O., Gungor O., Oztop I., Dirioz M., Yilmaz U. Quality of life, anxiety, and depression in Turkish colorectal cancer patients. Support Care Cancer 2010, 18(4):417-421.
107. Wasteson E., Brenne E., Higginson I.J., Hotopf M., Lloyd-Williams M., Kaasa S., et al. Depression assessment and classification in palliative cancer patients: a systematic literature review. Palliat Med 2009, 23(8):739-753.
108. Filazoglu G., Griva K. Coping and social support and health related quality of life in women with breast cancer in Turkey. Psychol Health Med 2008, 13(5):559-573.
109. Ozkan S., Ogce F. Importance of social support for functional status in breast cancer patients. Asian Pac J Cancer Prev 2008, 9(4):601-604.
110. Jafari N., Zamani A., Lazenby M., Farajzadegan Z., Emami H., Loghmani A. Translation and validation of the Persian version of the functional assessment of chronic illness therapy - spiritual Well-being Scale (FACIT-Sp) among muslim Iranians in treatment for cancer. Palliat Support Care 2013, 11(1):29-35.
111. Choumanova I., Wanat S., Barrett R., Koopman C. Religion and spirituality in coping with breast cancer: perspectives of Chilean women. Breast J 2006, 12(4):349-352.
112. Lazenby M., Khatib J., Al-Khair F., Neamat M. Psychometric properties of the functional assessment of chronic illness therapy - spiritual well-being (FACIT-Sp) in an Arabic-speaking, predominantly Muslim population. Psychooncology 2013, 22(1):220-227.
113. Lim J.W., Yi J. The effects of religiosity, spirituality, and social support on quality of life: a comparison between Korean American and Korean breast and gynecologic cancer survivors. Oncol Nurs Forum 2009, 36(6):699-708.
114. Gaston-Johansson F., Haisfield-Wolfe M.E., Reddick B., Goldstein N., Lawal T.A. The relationships among coping strategies, religious coping, and spirituality in African American women with breast cancer receiving chemotherapy. Oncol Nurs Forum 2013, 40(2):120-131.
115. Wildes K.A., Miller A.R., de Majors S.S., Ramirez A.G. The religiosity/spirituality of Latina breast cancer survivors and influence on health-related quality of life. Psychooncology 2009, 18(8):831-840.
116. Ku Y.L., Kuo S.M., Yao C.Y. Establishing the validity of a spiritual distress scale for cancer patients hospitalized in southern Taiwan. Int J Palliat Nurs 2010, 16(3):134-138.
117. Yong J., Kim J., Han S.S., Puchalski C.M. Development and validation of a scale assessing spiritual needs for Korean patients with cancer. JPalliat Care 2008, 24(4):240-246.
118. Purnell J.Q., Andersen B.L., Wilmot J.P. Religious practice and spirituality in the psychological adjustment of survivors of breast cancer. Couns Values 2009, 53(3):165.
119. Djuric Z., Mirasolo J., Kimbrough L., Brown D.R., Heilbrun L.K., Canar L., et al. Apilot trial of spirituality counseling for weight loss maintenance in African American breast cancer survivors. JNatl Med Assoc 2009, 101(6):552-564.
120. Clarke D., Martinez A., Cox R.S., Goffinet D.R. Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy. Cancer 1982, 49(11):2295-2299.
121. Bevilacqua J.L., Kattan M.W., Changhong Y., Koifman S., Mattos I.E., Koifman R.J., et al. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol 2012, 19(8):2580-2589.
122. Gralow J.R., Biermann J.S., Farooki A., Fornier M.N., Gagel R.F., Kumar R.N., et al. NCCN Task Force report: bone health in cancer care. JNatl Compr Cancer Netw 2009, 7(Suppl.3):S1-S32. [quiz S3-5].
123. Winters-Stone K.M., Schwartz A.L., Hayes S.C., Fabian C.J., Campbell K.L. Aprospective model of care for breast cancer rehabilitation: bone health and arthralgias. Cancer 2012, 118(Suppl.8):2288-2299.
124. Hillner B.E., Ingle J.N., Chlebowski R.T., Gralow J., Yee G.C., Janjan N.A., et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. JClin Oncol 2003, 21(21):4042-4057.
125. Kohrt W.M., Bloomfield S.A., Little K.D., Nelson M.E., Yingling V.R. American College of Sports Medicine Position Stand: physical activity and bone health. Med Sci Sports Exerc 2004, 36(11):1985-1996.
126. Grunberg S.M., Warr D., Gralla R.J., Rapoport B.L., Hesketh P.J., Jordan K., et al. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity - state of the art. Support Care Cancer 2011, 19(Suppl.1):S43-S47.
127. Roila F., Warr D., Aapro M., Clark-Snow R.A., Einhorn L., Gralla R.J., et al. Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only). Support Care Cancer 2011, 19(Suppl.1):S57-S62.
128. Roscoe J.A., Morrow G.R., Aapro M.S., Molassiotis A., Olver I. Anticipatory nausea and vomiting. Support Care Cancer 2011, 19(10):1533-1538.
129. Grunberg S.M., Osoba D., Hesketh P.J., Gralla R.J., Borjeson S., Rapoport B.L., et al. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity - an update. Support Care Cancer 2005, 13(2):80-84.
130. Herrstedt J., Rapoport B., Warr D., Roila F., Bria E., Rittenberg C., et al. Acute emesis: moderately emetogenic chemotherapy. Support Care Cancer 2011, 19(Suppl.1):S15-S23.
131. Kris M.G., Tonato M., Bria E., Ballatori E., Espersen B., Herrstedt J., et al. Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy. Support Care Cancer 2011, 19(Suppl.1):S25-S32.
132. Roila F., Warr D., Clark-Snow R.A., Tonato M., Gralla R.J., Einhorn L.H., et al. Delayed emesis: moderately emetogenic chemotherapy. Support Care Cancer 2005, 13(2):104-108.
133. Kumar S., Juresic E., Barton M., Shafiq J. Management of skin toxicity during radiation therapy: a review of the evidence. JMed Imaging Radiat Oncol 2010, 54(3):264-279.
134. Kraus-Tiefenbacher U., Sfintizky A., Welzel G., Simeonova A., Sperk E., Siebenlist K., et al. Factors of influence on acute skin toxicity of breast cancer patients treated with standard external beam radiotherapy (EBRT) after breast conserving surgery (BCS). Radiat Oncol 2012, 7(1):217.
135. Kane R.C., McGuinn W.D., Dagher R., Justice R., Pazdur R. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy. Oncologist 2008, 13(4):445-450.
136. Hemati S., Asnaashari O., Sarvizadeh M., Motlagh B.N., Akbari M., Tajvidi M., et al. Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer. Support Care Cancer 2012, 20(8):1613-1618.
137. Richardson P.G., Briemberg H., Jagannath S., Wen P.Y., Barlogie B., Berenson J., et al. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. JClin Oncol 2006, 24(19):3113-3120.
138. Hershman D.L., Weimer L.H., Wang A., Kranwinkel G., Brafman L., Fuentes D., et al. Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 2011, 125(3):767-774.
139. Loprinzi C.L., Maddocks-Christianson K., Wolf S.L., Rao R.D., Dyck P.J., Mantyh P. The paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J 2007, 13(6):399-403.
140. Loprinzi C.L., Reeves B.N., Dakhil S.R., Sloan J.A., Wolf S.L., Burger K.N., et al. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. JClin Oncol 2011, 29(11):1472-1478.
141. Reeves B.N., Dakhil S.R., Sloan J.A., Wolf S.L., Burger K.N., Kamal A., et al. Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1. Cancer 2012, 118(20):5171-5178.
142. Argyriou A.A., Assimakopoulos K., Iconomou G., Giannakopoulou F., Kalofonos H.P. Either called "chemobrain"or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real. JPain Symptom Manage 2010, [Epub ahead of print].
143. Cheung Y.T., Shwe M., Chui W.K., Chay W.Y., Ang S.F., Dent R.A., et al. Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients. Ann Pharmacother 2012, 46(12):1645-1655.
144. Rajagopal M. Setting up a pain management program. In: Kopf A, Patel N, editors. Guide to pain management in low-resource settings. Washington D.C.: International Association for the Study of Pain (IASP). p. 317-320.
145. Wolf S.L., Barton D.L., Qin R., Wos E.J., Sloan J.A., Liu H., et al. The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer 2012, 20(3):625-632.
146. Kuroi K., Shimozuma K., Ohashi Y., Takeuchi A., Aranishi T., Morita S., et al. Aquestionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer. Jpn J Clin Oncol 2008, 38(11):748-754.
147. Stubblefield M.D., McNeely M.L., Alfano C.M., Mayer D.K. Aprospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy. Cancer 2012, 118(Suppl.8):2250-2260.
148. Patarica-Huber E., Boskov N., Pjevic M. Multimodal approach to therapy-related neuropathic pain in breast cancer. JBUON 2011, 16(1):40-45.
149. Ripamonti C., Bruera E. Pain and symptom management in palliative care. Cancer Control 1996, 3(3):204-213.
150. Dutta V. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer. JCancer Res Ther 2011, 7(3):264-269.
151. Barton D.L., Wos E.J., Qin R., Mattar B.I., Green N.B., Lanier K.S., et al. Adouble-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer 2011, 19(6):833-841.
152. Rao R.D., Michalak J.C., Sloan J.A., Loprinzi C.L., Soori G.S., Nikcevich D.A., et al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 2007, 110(9):2110-2118.
153. Aapro M., Osterborg A., Gascon P., Ludwig H., Beguin Y. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol 2012, 23(8):1954-1962.
154. Renner P., Milazzo S., Liu J.P., Zwahlen M., Birkmann J., Horneber M. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. Cochrane Database Syst Rev 2012, 10:CD007913.
155. McNeely M.L., Courneya K.S. Exercise programs for cancer-related fatigue: evidence and clinical guidelines. JNatl Compr Cancer Netw 2010, 8(8):945-953.
156. Kangas M., Bovbjerg D.H., Montgomery G.H. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 2008, 134(5):700-741.
157. Cramp F., Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012, 11:CD006145.
158. Reif K., de Vries U., Petermann F., Gorres S. Apatient education program is effective in reducing cancer-related fatigue: a multi-centre randomised two-group waiting-list controlled intervention trial. Eur J Oncol Nurs 2013, 17(2):204-213.
159. Koopman C., Nouriani B., Erickson V., Anupindi R., Butler L.D., Bachmann M.H., et al. Sleep disturbances in women with metastatic breast cancer. Breast J 2002, 8(6):362-370.
160. McChargue D.E., Sankaranarayanan J., Visovsky C.G., Matthews E.E., Highland K.B., Berger A.M. Predictors of adherence to a behavioral therapy sleep intervention during breast cancer chemotherapy. Support Care Cancer 2012, 20(2):245-252.
161. Mosher C.E., Duhamel K.N. An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psychooncology 2012, 21(1):100-107.
162. van den Beuken-van Everdingen M.H., de Rijke J.M., Kessels A.G., Schouten H.C., van Kleef M., Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007, 18(9):1437-1449.
163. Azim H.A., de Azambuja E., Colozza M., Bines J., Piccart M.J. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol 2011, 22(9):1939-1947.
164. Andersen B.L., Jochimsen P.R. Sexual functioning among breast cancer, gynecologic cancer, and healthy women. JConsult Clin Psychol 1985, 53(1):25-32.
165. Munshi A., Dutta D., Kakkar S., Budrukkar A., Jalali R., Sarin R., et al. Comparison of early quality of life in patients treated with radiotherapy following mastectomy or breast conservation therapy: a prospective study. Radiother Oncol 2010, 97(2):288-293.
166. Shoma A.M., Mohamed M.H., Nouman N., Amin M., Ibrahim I.M., Tobar S.S., et al. Body image disturbance and surgical decision making in Egyptian post menopausal breast cancer patients. World J Surg Oncol 2009, 7:66.
167. Ruddy K.J., Gelber S., Ginsburg E.S., Schapira L., Abusief M.E., Meyer M.E., et al. Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls. Menopause 2011, 18(1):105-108.
168. Ruddy K.J., Partridge A.H. Fertility (male and female) and menopause. JClin Oncol 2012, 30(30):3705-3711.
169. Alicikus Z.A., Gorken I.B., Sen R.C., Kentli S., Kinay M., Alanyali H., et al. Psychosexual and body image aspects of quality of life in Turkish breast cancer patients: a comparison of breast conserving treatment and mastectomy. Tumori 2009, 95(2):212-218.
170. Bukovic D., Fajdic J., Hrgovic Z., Kaufmann M., Hojsak I., Stanceric T. Sexual dysfunction in breast cancer survivors. Onkologie 2005, 28(1):29-34.
171. Hill E.K., Sandbo S., Abramsohn E., Makelarski J., Wroblewski K., Wenrich E.R., et al. Assessing gynecologic and breast cancer survivors' sexual health care needs. Cancer 2011, 117(12):2643-2651.
172. Taylor S., Harley C., Ziegler L., Brown J., Velikova G. Interventions for sexual problems following treatment for breast cancer: a systematic review. Breast Cancer Res Treat 2011, 130(3):711-724.
173. King J.W., Davies M.C., Roche N., Abraham J.M., Jones A.L. Fertility preservation in women undergoing treatment for breast cancer in the U.K.: a questionnaire study. Oncologist 2012, 17(7):910-916.
174. Niemasik E.E., Letourneau J., Dohan D., Katz A., Melisko M., Rugo H., et al. Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors. JCancer Surviv 2012, 6(3):324-332.
175. Partridge A.H., Gelber S., Peppercorn J., Sampson E., Knudsen K., Laufer M., et al. Web-based survey of fertility issues in young women with breast cancer. JClin Oncol 2004, 22(20):4174-4183.
176. Lee S.J., Schover L.R., Partridge A.H., Patrizio P., Wallace W.H., Hagerty K., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. JClin Oncol 2006, 24(18):2917-2931.
177. Kreps G.L., Sivaram R. Strategic health communication across the continuum of breast cancer care in limited-resource countries. Cancer 2008, 113(Suppl.8):2331-2337.
178. Stanton A.L., Ganz P.A., Kwan L., Meyerowitz B.E., Bower J.E., Krupnick J.L., et al. Outcomes from the moving beyond cancer psychoeducational, randomized, controlled trial with breast cancer patients. JClin Oncol 2005, 23(25):6009-6018.
179. Schmid-Buchi S., Halfens R.J., Dassen T., van den Borne B. Psychosocial problems and needs of posttreatment patients with breast cancer and their relatives. Eur J Oncol Nurs 2011, 15(3):260-266.
180. Girgis A., Lambert S.D., McElduff P., Bonevski B., Lecathelinais C., Boyes A., et al. Some things change, some things stay the same: a longitudinal analysis of cancer caregivers' unmet supportive care needs. Psychooncology 2013, 22(7):1557-1564.
181. Tanna N., Buijs H., Pitkin J. Exploring the breast cancer patient journey: do breast cancer survivors need menopause management support?. Menopause Int 2011, 17(4):126-131.
182. Uddin N., Fateem E., Hablas A., Seifeldin I.A., Brown E., Merajver S.D., et al. Public and professional educational needs for downstaging breast cancer in Egypt. JCancer Educ 2012, 27(1):149-155.
183. Singh-Carlson S., Wong F., Martin L., Nguyen S.K. Breast cancer survivorship and South Asian women: understanding about the follow-up care plan and perspectives and preferences for information post treatment. Curr Oncol 2013, 20(2):e63-e79.
184. Disipio T., Rye S., Newman B., Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013, 14(6):500-515.
185. Torino F., Barnabei A., De Vecchis L., Appetecchia M., Strigari L., Corsello S.M. Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. Endocr Relat Cancer 2012, 19(2):R21-R33.
186. Shamieh O., Jazieh A.R. Modification and implementation of NCCN guidelines on palliative care in the Middle East and North Africa region. JNatl Compr Cancer Netw 2010, 8(Suppl.3):S41-S47. Committee MCPCRG.
187. Hooning M.J., Botma A., Aleman B.M., Baaijens M.H., Bartelink H., Klijn J.G., et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. JNatl Cancer Inst 2007, 99(5):365-375.
188. Aziz Z., Sana S., Akram M., Saeed A. Socioeconomic status and breast cancer survival in Pakistani women. JPak Med Assoc 2004, 54(9):448-453.
189. Karademas E.C., Argyropoulou K., Karvelis S. Psychological symptoms of breast cancer survivors: a comparison with matched healthy controls and the association with cancer-related stress and coping. JPsychosoc Oncol 2007, 25(3):59-74.
190. Lee M.K., Son B.H., Hwang S.Y., Han W., Yang J.H., Lee S., et al. Factors affecting health-related quality of life in women with recurrent breast cancer in Korea. Qual Life Res 2007, 16(4):559-569.
191. Abu-Saad Huijer H., Abboud S. Health-related quality of life among breast cancer patients in Lebanon. Eur J Oncol Nurs 2012, 16(5):491-497.
192. Abu-Saad Huijer H., Abboud S., Doumit M. Symptom prevalence and management of cancer patients in Lebanon. JPain Symptom Manage 2012, 44(3):386-399.
193. Hutter N., Vogel B., Alexander T., Baumeister H., Helmes A., Bengel J. Are depression and anxiety determinants or indicators of quality of life in breast cancer patients?. Psychol Health Med 2012, 18(4):412-419.
194. Kyranou M., Paul S.M., Dunn L.B., Puntillo K., Aouizerat B.E., Abrams G., et al. Differences in depression, anxiety, and quality of life between women with and without breast pain prior to breast cancer surgery. Eur J Oncol Nurs 2012, 17(2):190-195.
195. Carlson L.E., Waller A., Groff S.L., Bultz B.D. Screening for distress, the sixth vital sign, in lung cancer patients: effects on pain, fatigue, and common problems-secondary outcomes of a randomized controlled trial. Psychooncology 2013, 22(8):1881-1888.
196. Hewitt M., Greenfield S., Stovall E. From cancer patient to cancer survivor: lost in transition 2006, The National Academies Press, Washington DC.
197. WHO. Palliative care. World Health Organization. Available from: http://www.who.int/cancer/palliative/en/.
198. Shyyan R., Sener S.F., Anderson B.O., Garrote L.M., Hortobagyi G.N., Ibarra J.A., et al. Guideline implementation for breast healthcare in low- and middle-income countries: diagnosis resource allocation. Cancer 2008, 113(Suppl.8):2257-2268.